FDA Inspection
Reproductive Genetic Innovations LLCReproductive Genetic Innovations LLC – FDA Inspection, Sep 11, 2017
Record Details
This FDA Inspection record concerns Reproductive Genetic Innovations LLC, with an inspection on September 11, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Leeterry Moore (Issuing Officer)
View Company Profile
ID · 6b980aac-322f-4087-be7c-0ed986c35c75
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1025621
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Reproductive Genetic Innovations LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 3, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 13, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 24, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Genetic Innovations LLC
- FDA Inspection 1333178 - 2026-08-24
- FDA Inspection 1207914 - 2023-05-03
- FDA Inspection 891241 - 2014-08-13
- FDA Inspection 631545 - 2009-11-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.